Effect of tamoxifen and transdermal hormone replacement therapy on cardiovascular risk factors in a prevention trial. Italian Chemoprevention Group (Q36115270)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Effect of tamoxifen and transdermal hormone replacement therapy on cardiovascular risk factors in a prevention trial. Italian Chemoprevention Group	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Effect of tamoxifen and transdermal hormone replacement therapy on cardiovascular risk factors in a prevention trial. Italian Chemoprevention Group (English)

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Hormone Replacement Therapy

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

7

object named as

Boyle P

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Patrick Maisonneuve

5

object named as

Maisonneuve P

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Gianluca Severi

4

object named as

Severi G

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

author name string

Decensi A

1

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Robertson C

2

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Rotmensz N

3

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Sacchini V

6

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Costa A

8

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Veronesi U

9

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

language of work or name

0 references

publication date

1 September 1998

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

78

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

5

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

572-578

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Postmenopausal hormone therapy and mortality.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063049

2 October 2017

A realistic clinical perspective of tamoxifen and endometrial carcinogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063049

2 October 2017

Estrogen receptors: bioactivities and interactions with cell signaling pathways

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063049

2 October 2017

Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063049

2 October 2017

Hormonal treatment of postmenopausal women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063049

2 October 2017

Use of tamoxifen for breast cancer: twenty-eight years later

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063049

2 October 2017

Cardiac and vascular morbidity in women receiving adjuvant tamoxifen for breast cancer in a randomised trial. The Scottish Cancer Trials Breast Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063049

2 October 2017

Emerging delivery systems for estrogen replacement: aspects of transdermal and oral delivery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063049

2 October 2017

Early menopause and the risk of myocardial infarction.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063049

2 October 2017

Evaluation of methods for the measurement of low-density lipoprotein cholesterol.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063049

2 October 2017

Blood platelet count and function are related to total and cardiovascular death in apparently healthy men

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063049

2 October 2017

The prevention and treatment of osteoporosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063049

2 October 2017

The effect of tamoxifen and hormone replacement therapy on serum cholesterol, bone mineral density and coagulation factors in healthy postmenopausal women participating in a randomised, controlled tamoxifen prevention study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063049

2 July 2018

Cardiac and thromboembolic morbidity among postmenopausal women with early-stage breast cancer in a randomized trial of adjuvant tamoxifen. The Stockholm Breast Cancer Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063049

2 July 2018

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063049

2 July 2018

Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063049

2 July 2018

Transdermal 17 beta-estradiol combined with oral progestogen increases plasma levels of insulin-like growth factor-I in postmenopausal women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063049

2 July 2018

Coronary heart disease mortality and adjuvant tamoxifen therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063049

23 September 2018

Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063049

23 September 2018

The Royal Marsden Hospital pilot tamoxifen chemoprevention trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063049

23 September 2018

Differential effects of oral estrone versus 17 beta-estradiol on lipoproteins in postmenopausal women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063049

23 September 2018

Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063049

5 December 2018

Platelets and coronary artery disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/9744493

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholesterol and coronary heart disease: predicting risks by levels and ratios

1 reference

https://pubmed.ncbi.nlm.nih.gov/9744493

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of an estrogen response element activated by metabolites of 17beta-estradiol and raloxifene

1 reference

https://pubmed.ncbi.nlm.nih.gov/9744493

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug's link to genes reveals estrogen's many sides

1 reference

https://pubmed.ncbi.nlm.nih.gov/9744493

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of postmenopausal hormone replacement with oral and transdermal estrogen on high density lipoprotein metabolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/9744493

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/9744493

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Postmenopausal hormone use and risk of large-bowel cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9744493

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Breast Cancer Prevention Trial shows major benefit, some risk

1 reference

https://pubmed.ncbi.nlm.nih.gov/9744493

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biologic effects of transdermal estradiol

1 reference

https://pubmed.ncbi.nlm.nih.gov/9744493

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An analysis of randomized trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence

1 reference

https://pubmed.ncbi.nlm.nih.gov/9744493

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Different hepatobiliary effects of oral and transdermal estradiol in postmenopausal women

1 reference

https://pubmed.ncbi.nlm.nih.gov/9744493

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Symptoms associated with tamoxifen treatment in postmenopausal women

1 reference

https://pubmed.ncbi.nlm.nih.gov/9744493

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alteration of endocrine parameters in premenopausal women with breast cancer during long-term adjuvant therapy with tamoxifen as the single agent

1 reference

https://pubmed.ncbi.nlm.nih.gov/9744493

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

White blood cell count, coronary heart disease, and death: the NHANES I Epidemiologic Follow-up Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/9744493

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hormone replacement after breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9744493

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural killer cell activity, phagocytosis, and number of peripheral blood cells in breast cancer patients treated with tamoxifen

1 reference

https://pubmed.ncbi.nlm.nih.gov/9744493

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1998.542

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36115270&oldid=2198221087"